{"blog_url":"https://ctd-gim.hatenablog.com/","url":"https://ctd-gim.hatenablog.com/entry/2023/12/19/192443","title":"ANCA\u95a2\u9023\u8840\u7ba1\u708e\u7dad\u6301\u7642\u6cd5\u306eRTX\u306e\u6307\u6a19\u306fANCA\u3068B\u7d30\u80de\u6570\u3069\u3061\u3089\u304c\u826f\u3044\u304b\uff1f(MAINTANCAVAS study)","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2023%2F12%2F19%2F192443\" title=\"ANCA\u95a2\u9023\u8840\u7ba1\u708e\u7dad\u6301\u7642\u6cd5\u306eRTX\u306e\u6307\u6a19\u306fANCA\u3068B\u7d30\u80de\u6570\u3069\u3061\u3089\u304c\u826f\u3044\u304b\uff1f(MAINTANCAVAS study) - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","published":"2023-12-19 19:24:43","height":"190","type":"rich","author_url":"https://blog.hatena.ne.jp/CTD_GIM/","categories":["ANCA\u95a2\u9023\u8840\u7ba1\u708e","\u6cbb\u7642\u85ac"],"author_name":"CTD_GIM","description":"Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial | Annals of the Rheumatic Diseases Annals of the Rheumatic Diseases Published Online First: 11 December 2023. doi: 10.1136/ard-2023-224489 ANCA\u95a2\u9023\u8840\u7ba1\u708e\u306e\u7dad\u6301\u7642\u6cd5\u306f\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\uff08RTX\uff09\u304c\u30b9\u30bf\u30f3\u2026","version":"1.0","blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","image_url":null,"provider_name":"Hatena Blog","provider_url":"https://hatena.blog","width":"100%"}